Intas Pharms Usa Company Profile
✉ Email this page to a colleague
What is the competitive landscape for INTAS PHARMS USA, and what generic and branded alternatives to INTAS PHARMS USA drugs are available?
INTAS PHARMS USA has one approved drug.
Drugs and US Patents for Intas Pharms Usa
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Intas Pharms Usa | IRINOTECAN HYDROCHLORIDE | irinotecan hydrochloride | INJECTABLE;INJECTION | 203054-002 | Aug 31, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Intas Pharms Usa | IRINOTECAN HYDROCHLORIDE | irinotecan hydrochloride | INJECTABLE;INJECTION | 203054-001 | Aug 31, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.